Cargando…

Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates

BACKGROUND: The development of a vaccine against dengue faces unique challenges, including the complexity of the immune responses to the four antigenically distinct serotypes. Genome-wide transcriptional profiling provides insight into the pathways and molecular features that underlie responses to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Strouts, Fiona R., Popper, Stephen J., Partidos, Charalambos D., Stinchcomb, Dan T., Osorio, Jorge E., Relman, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877054/
https://www.ncbi.nlm.nih.gov/pubmed/27214236
http://dx.doi.org/10.1371/journal.pntd.0004731
_version_ 1782433321344565248
author Strouts, Fiona R.
Popper, Stephen J.
Partidos, Charalambos D.
Stinchcomb, Dan T.
Osorio, Jorge E.
Relman, David A.
author_facet Strouts, Fiona R.
Popper, Stephen J.
Partidos, Charalambos D.
Stinchcomb, Dan T.
Osorio, Jorge E.
Relman, David A.
author_sort Strouts, Fiona R.
collection PubMed
description BACKGROUND: The development of a vaccine against dengue faces unique challenges, including the complexity of the immune responses to the four antigenically distinct serotypes. Genome-wide transcriptional profiling provides insight into the pathways and molecular features that underlie responses to immune system stimulation, and may facilitate predictions of immune protection. METHODOLOGY/PRINCIPAL FINDINGS: In this study, we measured early transcriptional responses in the peripheral blood of cynomolgus macaques following vaccination with a live, attenuated tetravalent dengue vaccine candidate, TDV, which is based on a DENV-2 backbone. Different doses and routes of vaccine administration were used, and viral load and neutralizing antibody titers were measured at different time-points following vaccination. All 30 vaccinated animals developed a neutralizing antibody response to each of the four dengue serotypes, and only 3 of these animals had detectable serum viral RNA after challenge with wild-type dengue virus (DENV), suggesting protection of vaccinated animals to DENV infection. The vaccine induced statistically significant changes in 595 gene transcripts on days 1, 3, 5 and 7 as compared with baseline and placebo-treated animals. Genes involved in the type I interferon (IFN) response, including IFI44, DDX58, MX1 and OASL, exhibited the highest fold-change in transcript abundance, and this response was strongest following double dose and subcutaneous (versus intradermal) vaccine administration. In addition, modules of genes involved in antigen presentation, dendritic cell activation, and T cell activation and signaling were enriched following vaccination. Increased abundance of gene transcripts related to T cell activation on day 5, and the type I IFN response on day 7, were significantly correlated with the development of high neutralizing antibody titers on day 30. CONCLUSIONS/SIGNIFICANCE: These results suggest that early transcriptional responses may be predictive of development of adaptive immunity to TDV vaccination in cynomolgus macaques, and will inform studies of human responses to dengue vaccines.
format Online
Article
Text
id pubmed-4877054
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48770542016-06-09 Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates Strouts, Fiona R. Popper, Stephen J. Partidos, Charalambos D. Stinchcomb, Dan T. Osorio, Jorge E. Relman, David A. PLoS Negl Trop Dis Research Article BACKGROUND: The development of a vaccine against dengue faces unique challenges, including the complexity of the immune responses to the four antigenically distinct serotypes. Genome-wide transcriptional profiling provides insight into the pathways and molecular features that underlie responses to immune system stimulation, and may facilitate predictions of immune protection. METHODOLOGY/PRINCIPAL FINDINGS: In this study, we measured early transcriptional responses in the peripheral blood of cynomolgus macaques following vaccination with a live, attenuated tetravalent dengue vaccine candidate, TDV, which is based on a DENV-2 backbone. Different doses and routes of vaccine administration were used, and viral load and neutralizing antibody titers were measured at different time-points following vaccination. All 30 vaccinated animals developed a neutralizing antibody response to each of the four dengue serotypes, and only 3 of these animals had detectable serum viral RNA after challenge with wild-type dengue virus (DENV), suggesting protection of vaccinated animals to DENV infection. The vaccine induced statistically significant changes in 595 gene transcripts on days 1, 3, 5 and 7 as compared with baseline and placebo-treated animals. Genes involved in the type I interferon (IFN) response, including IFI44, DDX58, MX1 and OASL, exhibited the highest fold-change in transcript abundance, and this response was strongest following double dose and subcutaneous (versus intradermal) vaccine administration. In addition, modules of genes involved in antigen presentation, dendritic cell activation, and T cell activation and signaling were enriched following vaccination. Increased abundance of gene transcripts related to T cell activation on day 5, and the type I IFN response on day 7, were significantly correlated with the development of high neutralizing antibody titers on day 30. CONCLUSIONS/SIGNIFICANCE: These results suggest that early transcriptional responses may be predictive of development of adaptive immunity to TDV vaccination in cynomolgus macaques, and will inform studies of human responses to dengue vaccines. Public Library of Science 2016-05-23 /pmc/articles/PMC4877054/ /pubmed/27214236 http://dx.doi.org/10.1371/journal.pntd.0004731 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Strouts, Fiona R.
Popper, Stephen J.
Partidos, Charalambos D.
Stinchcomb, Dan T.
Osorio, Jorge E.
Relman, David A.
Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
title Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
title_full Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
title_fullStr Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
title_full_unstemmed Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
title_short Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates
title_sort early transcriptional signatures of the immune response to a live attenuated tetravalent dengue vaccine candidate in non-human primates
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877054/
https://www.ncbi.nlm.nih.gov/pubmed/27214236
http://dx.doi.org/10.1371/journal.pntd.0004731
work_keys_str_mv AT stroutsfionar earlytranscriptionalsignaturesoftheimmuneresponsetoaliveattenuatedtetravalentdenguevaccinecandidateinnonhumanprimates
AT popperstephenj earlytranscriptionalsignaturesoftheimmuneresponsetoaliveattenuatedtetravalentdenguevaccinecandidateinnonhumanprimates
AT partidoscharalambosd earlytranscriptionalsignaturesoftheimmuneresponsetoaliveattenuatedtetravalentdenguevaccinecandidateinnonhumanprimates
AT stinchcombdant earlytranscriptionalsignaturesoftheimmuneresponsetoaliveattenuatedtetravalentdenguevaccinecandidateinnonhumanprimates
AT osoriojorgee earlytranscriptionalsignaturesoftheimmuneresponsetoaliveattenuatedtetravalentdenguevaccinecandidateinnonhumanprimates
AT relmandavida earlytranscriptionalsignaturesoftheimmuneresponsetoaliveattenuatedtetravalentdenguevaccinecandidateinnonhumanprimates